Rapid RNA testing kits Market

Rapid RNA Testing Kits Market Overview

The global rapid RNA testing kits market was valued at around USD 5,890.0 Million at the end of 2021. The market is projected to register a 6.8% CAGR and top a valuation of USD 12,157.6 Million by 2032.

Growing advantages of rapid RNA testing kits such as it provides quick results, helps in reducing the spread of infection and prevent outbreaks are likely to propel the market for rapid RNA testing kits.

Rapid RNA testing kits are made with high sensitivity, cheap cost, fast response times, and ease of use in mind. The majority of these quick RNA testing kits provide results in less than an hour. Akonni Biosystems, Inc.'s TruTip Quick RNA Kit is one of the rapid RNA testing kits that comes in multiple configurations depending on the sample viscosity, i.e. low viscosity and high viscosity.

These quick RNA testing kits are used to diagnose a wide range of conditions and diseases as well as for research. Rapid RNA testing kits serve as point-of-care diagnostic tools for diseases like HIV, influenza, and others.

Rapid RNA testing kits are especially helpful in areas where pathology facilities are under-resourced and in low-income areas like Africa. The development of quick RNA testing kits for HIV is supported by WHO initiatives to lower the number of HIV cases worldwide.

Another issue is the rise of other infectious diseases like influenza, which demands for quick testing to guarantee prompt diagnosis and treatment. The typical sample types for these fast RNA testing kits are blood or urine. For some quick RNA testing kits, saliva may also be utilised as a sample source.

Attributes	Details
Rapid RNA Testing Kits Market Value in 2021	USD 5,890.0 Million
Rapid RNA Testing Kits Market Value in 2032	USD 12,157.6 Million
Rapid RNA Testing Kits Market CAGR (2022 to 2032)	6.8%

What are the Major Drivers Boosting the Demand for Rapid RNA Testing Kits Market?

The market for rapid RNA testing kits is expanding significantly as a result of increased biotechnology research as well as an increase in specific diseases and infections including HIV and influenza. Therefore, increasing prevalence of HIV and influenza is supposed to boost the market’s growth.

For instance, according to World Health Organization (WHO), in 2021, around 38.4 million people globally were suffering from HIV and about 6,50,000 people globally died due to HIV.

Moreover, growing benefits of rapid RNA testing kits such as faster results and ease of use are contributing to the market's increasing appeal. Additionally, chances of false positive or false negative result is low, which do not impact the results. This factors are supposed to stimulate the market growth over the forecast duration.

Which Region Shows Strong Growth Potential in the Rapid RNA Testing Kits Market?

The rapid RNA testing kits market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America dominated the regional rapid RNA testing kits market due to region’s supporting healthcare system. Additionally, presence of top key players such as GeneBio Systems Inc., Zymo Research, Akonni Biosystems, Inc., and Bioo Scientific in the region is supposed to boost the regional market for rapid RNA testing kits.

Moreover, the market for rapid RNA testing kits in Asia Pacific is predicted to expand at the fastest rate and with the highest CAGR during the forecast period due to the region's robust and changing government funding for research and healthcare.

Who are the Key Manufacturers in the Rapid RNA Testing Kits Market?

GeneBio Systems Inc., Akonni Biosystems, Inc., Zymo Research, Bioo Scientific, MP Biomedicals, LLC., ThermoFisher Scientific, Trivitron Healthcare, Genes2Me, and OPRL Biosciences Pvt.,Ltd.

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 6.8% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Million, Volume in Units, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Product Type, End-User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Spain, Italy, Russia, BENELUX, China, Japan, South Korea, India, Malaysia, Thailand, Indonesia, Australia, New Zealand, GCC Countries, South Africa, North Africa, Turkey
Key Players	GeneBio Systems Inc.; Akonni Biosystems, Inc.; Zymo Research; Bioo Scientific; MP Biomedicals, LLC.; ThermoFisher Scientific; Trivitron Healthcare; Genes2Me; OPRL Biosciences Pvt.,Ltd.
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. By Product Type
  • 6.2. By End-User
• 7. Global Market Analysis and Forecast, By Product Type
  • 7.1. Adenovirus Testing Kits
  • 7.2. Herpes Virus I Testing Kits
  • 7.3. Influenza A & B
  • 7.4. Others
• 8. Global Market Analysis and Forecast, By End-User
  • 8.1. Pharmaceutical & Biotech Companies
  • 8.2. Diagnostic Centres
  • 8.3. Academic and Research Institutions
• 9. Global Market Analysis and Forecast, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Europe
  • 9.4. East Asia
  • 9.5. South Asia
  • 9.6. Oceania
  • 9.7. The Middle East and Africa (MEA)
• 10. North America Sales Analysis and Forecast, by Key Segments and Countries
• 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 12. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 13. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 14. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 15. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 16. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 17. Sales Forecast by Product Type and End-User for 30 Countries
• 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 19. Company Profile
  • 19.1. GeneBio Systems Inc.
  • 19.2. Akonni Biosystems, Inc.
  • 19.3. Zymo Research
  • 19.4. Bioo Scientific
  • 19.5. MP Biomedicals, LLC.
  • 19.6. ThermoFisher Scientific
  • 19.7. Trivitron Healthcare
  • 19.8. Genes2Me
  • 19.9. OPRL Biosciences Pvt., Ltd